MarketScreener

Nucor Corporation Declares Quarterly Cash Dividend, Payable on November 10, 2026

The Board of Directors of Nucor Corporation declared the regular quarterly cash dividend of $0.56 per share on Nucor's common stock. This cash dividend is payable on November 10, 2026 to stockholders ...
MarketScreener

Nucor Keeps Quarterly Dividend at $0.56 a Share, Payable Nov. 10 to Shareholders of Record as of Sept. 30

Seaport Global Adjusts Price Target on Nucor to $310 From $285, Keeps Buy Rating MT Sep. 11 Goldman Sachs Adjusts Nucor Price Target to $304 From $303, Maintains Buy Rating MT Aug. 24 Wells Fargo ...

Novo Nordisk A/S: Novo's once-weekly Sogroya (somapacitan) receives positive CHMP opinion in Europe for children with idiopathic short stature (unexplained shortness)

If approved, Sogroya (somapacitan) would be the first and only growth hormone treatment approved for idiopathic short stature in the EU, providing a much-needed treatment option for children and their ...

F. Hoffmann-La Roche Ltd: CHMP recommends EU approval of Roche's Ocrevus for children and adolescents with relapsing multiple sclerosis

Ocrevus addresses a critical need in paediatric neurology as the first high- efficacy anti-CD20 treatment option for people with MS as young as 10 years old In the Phase III OPERETTA 2 study, Ocrevus ...